AIM: To compare pharmacological properties of heterologously expressed homomeric alpha7 nicotinic acetylcholine receptors (alpha7 nAChRs) with those of native nAChRs containing alpha7 subunit (alpha7* nAChRs) in rat hippocampus and cerebral cortex. METHODS: We established a stably transfected HEK-293 cell line that expresses homomeric rat alpha7 nAChRs. We studies ligand binding profiles and functional properties of nAChRs expressed in this cell line and native rat alpha7* nAChRs in rat hippocampus and cerebral cortex. We used [(125)I]-alpha-bungarotoxin to compare ligand binding profiles in these cells with those in rat hippocampus and cerebral cortex. The functional properties of the alpha7 nAChRs expressed in this cell line were studied using whole-cell current recording. RESULTS: The newly established cell line, KXalpha7R1, expresses homomeric alpha7 nAChRs that bind [(125)I]-alpha-bungarotoxin with a K(d) value of 0.38+/-0.06 nmol/L, similar to K(d) values of native rat alpha7* nAChRs from hippocampus (K(d)=0.28+/-0.03 nmol/L) and cerebral cortex (K(d)=0.33+/-0.05 nmol/L). Using whole-cell current recording, the homomeric alpha7 nAChRs expressed in the cells were activated by acetylcholine and (-)-nicotine with EC(50) values of 280+/-19 micromol/L and 180+/-40 micromol/L, respectively. The acetylcholine activated currents were potently blocked by two selective antagonists of alpha7 nAChRs, alpha-bungarotoxin (IC(50)=19+/-2 nmol/L) and methyllycaconitine (IC(50)=100+/-10 pmol/L). A comparative study of ligand binding profiles, using 13 nicotinic ligands, showed many similarities between the homomeric alpha7 nAChRs and native alpha7* receptors in rat brain, but it also revealed several notable differences. CONCLUSION: This newly established stable cell line should be very useful for studying the properties of homomeric alpha7 nAChRs and comparing these properties to native alpha7* nAChRs.
AIM: To compare pharmacological properties of heterologously expressed homomeric alpha7 nicotinic acetylcholine receptors (alpha7 nAChRs) with those of native nAChRs containing alpha7 subunit (alpha7* nAChRs) in rat hippocampus and cerebral cortex. METHODS: We established a stably transfected HEK-293 cell line that expresses homomeric rat alpha7 nAChRs. We studies ligand binding profiles and functional properties of nAChRs expressed in this cell line and native rat alpha7* nAChRs in rat hippocampus and cerebral cortex. We used [(125)I]-alpha-bungarotoxin to compare ligand binding profiles in these cells with those in rat hippocampus and cerebral cortex. The functional properties of the alpha7 nAChRs expressed in this cell line were studied using whole-cell current recording. RESULTS: The newly established cell line, KXalpha7R1, expresses homomeric alpha7 nAChRs that bind [(125)I]-alpha-bungarotoxin with a K(d) value of 0.38+/-0.06 nmol/L, similar to K(d) values of native rat alpha7* nAChRs from hippocampus (K(d)=0.28+/-0.03 nmol/L) and cerebral cortex (K(d)=0.33+/-0.05 nmol/L). Using whole-cell current recording, the homomeric alpha7 nAChRs expressed in the cells were activated by acetylcholine and (-)-nicotine with EC(50) values of 280+/-19 micromol/L and 180+/-40 micromol/L, respectively. The acetylcholine activated currents were potently blocked by two selective antagonists of alpha7 nAChRs, alpha-bungarotoxin (IC(50)=19+/-2 nmol/L) and methyllycaconitine (IC(50)=100+/-10 pmol/L). A comparative study of ligand binding profiles, using 13 nicotinic ligands, showed many similarities between the homomeric alpha7 nAChRs and native alpha7* receptors in rat brain, but it also revealed several notable differences. CONCLUSION: This newly established stable cell line should be very useful for studying the properties of homomeric alpha7 nAChRs and comparing these properties to native alpha7* nAChRs.
Authors: E X Albuquerque; M Alkondon; E F Pereira; N G Castro; A Schrattenholz; C T Barbosa; R Bonfante-Cabarcas; Y Aracava; H M Eisenberg; A Maelicke Journal: J Pharmacol Exp Ther Date: 1997-03 Impact factor: 4.030
Authors: E X Albuquerque; E F Pereira; N G Castro; M Alkondon; S Reinhardt; H Schröder; A Maelicke Journal: Ann N Y Acad Sci Date: 1995-05-10 Impact factor: 5.691
Authors: M Gopalakrishnan; B Buisson; E Touma; T Giordano; J E Campbell; I C Hu; D Donnelly-Roberts; S P Arneric; D Bertrand; J P Sullivan Journal: Eur J Pharmacol Date: 1995-08-15 Impact factor: 4.432
Authors: Gregory P Hussmann; Robert P Yasuda; Yingxian Xiao; Barry B Wolfe; Kenneth J Kellar Journal: J Biol Chem Date: 2011-09-22 Impact factor: 5.157
Authors: Małgorzata Dukat; Anna Wesołowska; Genevieve Alley; Shawquia Young; Galya R Abdrakhmanova; Hernán A Navarro; Richard Young; Richard A Glennon Journal: Psychopharmacology (Berl) Date: 2010-04-30 Impact factor: 4.530
Authors: Yongjun Gao; Ronnie C Mease; Thao T Olson; Kenneth J Kellar; Robert F Dannals; Martin G Pomper; Andrew G Horti Journal: Nucl Med Biol Date: 2014-12-20 Impact factor: 2.408
Authors: Yongjun Gao; Kenneth J Kellar; Robert P Yasuda; Thao Tran; Yingxian Xiao; Robert F Dannals; Andrew G Horti Journal: J Med Chem Date: 2013-09-19 Impact factor: 7.446
Authors: Ansel T Hillmer; Songye Li; Ming-Qiang Zheng; Matthias Scheunemann; Shu-Fei Lin; Nabeel Nabulsi; Daniel Holden; Richard Pracitto; David Labaree; Jim Ropchan; Rodrigo Teodoro; Winnie Deuther-Conrad; Irina Esterlis; Kelly P Cosgrove; Peter Brust; Richard E Carson; Yiyun Huang Journal: Eur J Nucl Med Mol Imaging Date: 2017-01-24 Impact factor: 9.236
Authors: Andrew G Horti; Yongjun Gao; Hiroto Kuwabara; Yuchuan Wang; Sofya Abazyan; Robert P Yasuda; Thao Tran; Yingxian Xiao; Niaz Sahibzada; Daniel P Holt; Kenneth J Kellar; Mikhail V Pletnikov; Martin G Pomper; Dean F Wong; Robert F Dannals Journal: J Nucl Med Date: 2014-02-20 Impact factor: 10.057
Authors: Adebowale E Ogunjirin; Joseph M Fortunak; LaVerne L Brown; Yingxian Xiao; Martha I Dávila-García Journal: Neurochem Res Date: 2015-10-27 Impact factor: 3.996